Phenomic technologies in drug discovery of neglected diseases
2011
Using Phenomic Technologies to Discover New Drugs for Neglected Diseases
Sample size: 200000
publication
Evidence: moderate
Author Information
Author(s): Nehrbass Ulf, Roberto Bruzzone
Primary Institution: Institut Pasteur-Korea
Hypothesis
Can phenomic technologies help in discovering new treatments for neglected diseases like Leishmaniasis, Chagas Disease, and Dengue?
Conclusion
The study successfully screened hundreds of thousands of compounds to find potential new drugs for neglected diseases.
Supporting Evidence
- Leishmaniasis, Chagas Disease, and Dengue are neglected diseases with high mortality rates.
- 200,000 drugs were screened for their effectiveness against Leishmaniasis.
- 150,000 compounds were screened for their ability to inhibit Trypanosoma cruzi in Chagas disease.
- High-throughput screening assays were developed for malaria targeting P. falciparum.
Takeaway
Scientists are using special technology to find new medicines for diseases that don't have good treatments right now.
Methodology
High-content/high-throughput screening assays were developed to test large numbers of compounds against pathogens inside human cells.
Want to read the original?
Access the complete publication on the publisher's website